Hasil Pencarian  ::  Simpan CSV :: Kembali

"Kehamilan diketahui sebagai salah satu faktor risiko utama terjadinya tromboemboli baik di arteri maupun vena, yang bisa meningkat sebanyak 4 sampai 5 kali. Venografi merupakan baku emas untuk diagnosis DVT namun karena invasif, tidak dilakukan pada wanita hamil. Thrombin Anti Thrombin complex (TAT) dan D-dimer (DD) adalah pemeriksaan yang secara klinis berguna untuk prediksi dan diagnosis trombosis. Namun kadar TAT dan DD akan meningkat dalam situasi yang bervariasi termasuk kehamilan.Penelitian ini bertujuan untuk mendapatkan gambaran kadar fibrin monomer pada kehamilan trimester 1, 2, dan 3. Terdapat 31 sampel masing-masing pada trimester 1, 2, dan 3. CV kontrol normal dan abnormal pemeriksaan fibrin monomer adalah 7.43% dan 3.51%. Kadar fibrin monomer menunjukkan distribusi tidak normal dengan nilai p = 0.001 (<0.05) sehingga data disajikan dalam nilai median dan nilai rentang. Berdasarkan nilai cutt off 6.0 μg/mL maka peningkatan kadar fibrin monomer dijumpai hanya pada trimester 3 yaitu sebesar 3.2%.Tidak terdapat perbedaan yang bermakna antara trimester 1 dan 2 (p=0.491), sedangkan antara trimester 1 dan 3 berbeda bermakna (p=0.004), begitu juga antara trimester 2 dan 3 (p=0.031), sehingga dapat dikatakan fibrin monomer kadarnya pada kehamilan relatif tetap.

---

Background: Pregnancy is known as a risk factor for thromboembolism at arterial and venous, which could rise as much as 4 to 5 times .Venography is the gold standard for the diagnosis of DVT, but because it is invasive, so it is not done on pregnant women. Thrombin anti-thrombin complex (TAT) and D-dimer, which are the clinical examination useful for the prediction and diagnosis of thrombosis. However, the concentration of TAT and D-dimer will be increased in various conditions, including pregnancy.

Aim: This study is to gain preview on the fibrin monomer for the first, second and third trimester of pregnancy.

Methods: A cross sectional study. There was 31 samples, respectively the first, second and third trimester of pregnancy. CV of normal and abnormal control of fibrin monomer was 7.43% and 3.51 %. Levels of fibrin monomer showed the abnormal distribution, with p = 0.001 (> 0.05), so data are presented as median values and value ranges. Based on the cut-off value of 6 μg/mL, then increased levels of fibrin monomer was only found in third trimester , which was 3.2%.

Result: There were no significant differences between the first and the second trimester of pregnancy (p = 0.491). There were significant differences between the first and third trimester of pregnancy (p=0.004) as well as between the second and third of pregnancy (p=0.031). Thus, fibrin monomer level was relatively constant during pregnancy.

Conclusion: fibrin monomer is relatively constant during pregnancy compared to D-dimer."

"ABSTRAK Hipertensi merupakan kelainan yang umum dijumpai pada kehamilan.Sekitar 70% wanita hamil mengalami gestational hypertension dan preeklampsia.Disfungsi endotel pada preeklampsia menyebabkan permukaan endotel yangnontrombogenik menjadi trombogenik sehingga dapat terjadi aktivasi koagulasi.Preeklampsia meningkatkan keadaan hiperkoagulabel yang sudah ada padakehamilan normal. Gestational hypertension pada wanita hamil adalah hipertensiyang tidak memenuhi kriteria preeklampsia. Hampir setengah dari pasien dengangestational hypertension akan berkembang menjadi preeklampsia. Fibrinmonomer merupakan petanda aktivasi koagulasi yang digunakan pada keadaan pretrombotik oleh karena terbentuk terlebih dahulu pada keadaan hiperkoagulabel daripada D-dimer yang terbentuk setelah fibrinolisis. Tujuan penelitian adalahmendapatkan gambaran fibrin monomer pada gestational hypertension danpreeklampsia. Penelitian ini adalah penelitian potong lintang pada 30 wanitahamil gestational hypertension dan 30 wanita hamil preeklampsia yang dilakukanpada Oktober sampai November 2015. Pemeriksaan FM menggunakan reagenSTA-Liatest memakai koagulometer STA Compact Analyzer. Kadar fibrinmonomer pada gestational hypertension didapatkan mean 4,61 µg/mL denganstandar deviasi 0,86 µg/mL. Kadar fibrin monomer pada preeklampsia didapatkanmedian 10,5 µg/mL dengan mean 11.99 µg/mL dan rentang 6,12 ? 23,26 µg/mL.Didapatkan perbedaan bermakna kadar fibrin monomer pada gestationalhypertension dan preeklampsia dengan nilai p<0,001.ABSTRACT Hypertension is a common disorder in pregnancy. Approximately 70% ofpregnant women is gestational hypertension and preeclampsia. Endothelialdysfunction in preeclampsia causes the endothelial surface of the nonthrombogenicbe thrombogenic so it can activated coagulation. Preeclampsiaincrease hypercoagulability state in normal pregnancy. Gestational hypertension isa hypertension in pregnancy who do not meet the criteria of preeclampsia. Nearlyhalf of patients with gestational hypertension develop into preeclampsia. Fibrinmonomers are used for coagulation activation marker on the prethrombotic statetherefore formed before on hypercoagulability state hiperkoagulabel than D-dimerformed after fibrinolysis. The objective of this study is to gain description offibrin monomer levels and it was a cross-sectional study 30 pregnant women withgestational hypertension and 30 pregnant women with preeclampsia. The studywas conducted in October and November 2015. Examination of fibrin monomerusing the reagent STA-Liatest and analyzer STA Compact. Mean of fibrinmonomer in gestational hypertension was 4.61 µg/mL with standard deviationwas 0.86 µg/mL. Median of fibrin monomer in preeclampsia was 10.5 µg / mLwith range was 6.12 to 23.26 µg/mL. Fibrin monomer levels found significantdifferences in gestational hypertension and preeclampsia with p <0.001.;Hypertension is a common disorder in pregnancy. Approximately 70% ofpregnant women is gestational hypertension and preeclampsia. Endothelialdysfunction in preeclampsia causes the endothelial surface of the nonthrombogenicbe thrombogenic so it can activated coagulation. Preeclampsiaincrease hypercoagulability state in normal pregnancy. Gestational hypertension isa hypertension in pregnancy who do not meet the criteria of preeclampsia. Nearlyhalf of patients with gestational hypertension develop into preeclampsia. Fibrinmonomers are used for coagulation activation marker on the prethrombotic statetherefore formed before on hypercoagulability state hiperkoagulabel than D-dimerformed after fibrinolysis. The objective of this study is to gain description offibrin monomer levels and it was a cross-sectional study 30 pregnant women withgestational hypertension and 30 pregnant women with preeclampsia. The studywas conducted in October and November 2015. Examination of fibrin monomerusing the reagent STA-Liatest and analyzer STA Compact. Mean of fibrinmonomer in gestational hypertension was 4.61 µg/mL with standard deviationwas 0.86 µg/mL. Median of fibrin monomer in preeclampsia was 10.5 µg / mLwith range was 6.12 to 23.26 µg/mL. Fibrin monomer levels found significantdifferences in gestational hypertension and preeclampsia with p <0.001.;Hypertension is a common disorder in pregnancy. Approximately 70% ofpregnant women is gestational hypertension and preeclampsia. Endothelialdysfunction in preeclampsia causes the endothelial surface of the nonthrombogenicbe thrombogenic so it can activated coagulation. Preeclampsiaincrease hypercoagulability state in normal pregnancy. Gestational hypertension isa hypertension in pregnancy who do not meet the criteria of preeclampsia. Nearlyhalf of patients with gestational hypertension develop into preeclampsia. Fibrinmonomers are used for coagulation activation marker on the prethrombotic statetherefore formed before on hypercoagulability state hiperkoagulabel than D-dimerformed after fibrinolysis. The objective of this study is to gain description offibrin monomer levels and it was a cross-sectional study 30 pregnant women withgestational hypertension and 30 pregnant women with preeclampsia. The studywas conducted in October and November 2015. Examination of fibrin monomerusing the reagent STA-Liatest and analyzer STA Compact. Mean of fibrinmonomer in gestational hypertension was 4.61 µg/mL with standard deviationwas 0.86 µg/mL. Median of fibrin monomer in preeclampsia was 10.5 µg / mLwith range was 6.12 to 23.26 µg/mL. Fibrin monomer levels found significantdifferences in gestational hypertension and preeclampsia with p <0.001.;Hypertension is a common disorder in pregnancy. Approximately 70% ofpregnant women is gestational hypertension and preeclampsia. Endothelialdysfunction in preeclampsia causes the endothelial surface of the nonthrombogenicbe thrombogenic so it can activated coagulation. Preeclampsiaincrease hypercoagulability state in normal pregnancy. Gestational hypertension isa hypertension in pregnancy who do not meet the criteria of preeclampsia. Nearlyhalf of patients with gestational hypertension develop into preeclampsia. Fibrinmonomers are used for coagulation activation marker on the prethrombotic statetherefore formed before on hypercoagulability state hiperkoagulabel than D-dimerformed after fibrinolysis. The objective of this study is to gain description offibrin monomer levels and it was a cross-sectional study 30 pregnant women withgestational hypertension and 30 pregnant women with preeclampsia. The studywas conducted in October and November 2015. Examination of fibrin monomerusing the reagent STA-Liatest and analyzer STA Compact. Mean of fibrinmonomer in gestational hypertension was 4.61 µg/mL with standard deviationwas 0.86 µg/mL. Median of fibrin monomer in preeclampsia was 10.5 µg / mLwith range was 6.12 to 23.26 µg/mL. Fibrin monomer levels found significantdifferences in gestational hypertension and preeclampsia with p <0.001.;Hypertension is a common disorder in pregnancy. Approximately 70% ofpregnant women is gestational hypertension and preeclampsia. Endothelialdysfunction in preeclampsia causes the endothelial surface of the nonthrombogenicbe thrombogenic so it can activated coagulation. Preeclampsiaincrease hypercoagulability state in normal pregnancy. Gestational hypertension isa hypertension in pregnancy who do not meet the criteria of preeclampsia. Nearlyhalf of patients with gestational hypertension develop into preeclampsia. Fibrinmonomers are used for coagulation activation marker on the prethrombotic statetherefore formed before on hypercoagulability state hiperkoagulabel than D-dimerformed after fibrinolysis. The objective of this study is to gain description offibrin monomer levels and it was a cross-sectional study 30 pregnant women withgestational hypertension and 30 pregnant women with preeclampsia. The studywas conducted in October and November 2015. Examination of fibrin monomerusing the reagent STA-Liatest and analyzer STA Compact. Mean of fibrinmonomer in gestational hypertension was 4.61 µg/mL with standard deviationwas 0.86 µg/mL. Median of fibrin monomer in preeclampsia was 10.5 µg / mLwith range was 6.12 to 23.26 µg/mL. Fibrin monomer levels found significantdifferences in gestational hypertension and preeclampsia with p <0.001."

"Secara umum di negara maju 95% wanita hamil mendapat pertolongan dokter dan 50% di antaranya ditolong oleh dokter ahli Obstetri dan Ginekologi, tetapi dinegara yang sedang berkembang pertolongan oleh dokter ahli Obstetri dan Ginekologi hanya 1% selebihnya mendapat bantuan bidan, perawat dan dukun beranak. Di Indonesia angka morbiditas dan mortalitas maternal maupun perinatal masih tinggi. Sebagai contoh angka kematian maternal di Indonesia pada tahun 1986 masih berkisar antara 400-450 per 100.000 kelahiran hidup, sedangkan di negara ASEAN lainnya seperti Malaysia 69 per 100.000 kelahiran hidup, Filipina 142 per 100.000 kelahiran hidup, Thailand 100 per 100.000 kelahiran hidup dan bahkan Singapura sudah mencapai 5 per 100.000 kelahiran hidup. Salah satu penyebab kematian ibu ini adalah perdarahan obstetrik disamping preeklampsia/eklampsia dan infeksi. I dan kawan kawan melaporkan bahwa di12 rumah sakit pendidikan di Indonesia antara 1977-1980 didapatkan angka kematian ibu terdiri dari perdarahan 30,4%, infeksi 22,2% dan pre/eklampsia 16,3%. Sedangkan Agustina selama tahun 1981-1982 di Rumah Sakit Hasan Sadikin Bandung menemukan proporsi komplikasi obstetrik sebagai berikut: perdarahan 37,5%, preeklampsia/eklampsia 28,5% dan infeksi 19,7%. Sukirna melaporkan bahwa selama tahun 1988 di Rumah Sakit Cipto Mangunkusumo Jakarta kematian maternal terdiri atas Preeklampsia/eklampsia 46,15%, perdarahan 33,3% dan infeksi 7,69%. Perdarahan obstetrik mempunyai penyebab bermacam macam, salah satu penyebab perdarahan adalah koagulasi intravaskular diseminata (KID) yang dapat pula disebabkan oleh patologi pendarahan. KID merupakan suatu keadaan di mana mekanisme pembekuan dan fibrinolisis bekerja pada saat yang bersamaan. KID bukan merupakan suatu penyakit tetapi merupakan suatu penyulit dari patologi solusio plasentae, preeklampsia, kematian janin, atonia uteri, robekan jalan lahir, sisa plasenta dan kelainan pembekuan darah. Kekerapan KID belum diketahui pasti tetapi beberapa penulis mencoba untuk mengungkapkannya di antaranya Phillips (1975) di Amerika Serikat yang mendapatkan 24,3% dari kasus kematian janin, 17,6% dari 34% kasus syok septik, dan 19% kasus preeklampsia /eklampsia. Di Indonesia Hudono (1981) mengatakan bahwa komplikasi obstetrik yang paling sering disertai penyulit ini adalah solusio plasentae (10-30%)?."

"Fibrin Tissue Adhesive (FTA), Fibrin Scalant (FS) or Fibrin Glue (FG) are names given to a group of product that lead to the formation clot at the site of application. Fibrin Glue represents a new revolution for local haemostatic, which produced by based on the understanding about blood coagulation process. The mechanism of FG mimics the last stage of blood coagulation process.Hemophilia, is a congenital inherited bleeding disorder, characterized by repeated bleeding episodes. The basic pathology is deficiency of factor VIII (hemophilia A) or factor IX (hemophilia B). A bleeding episodes, hemophilia patients need replacement therapy. Hemophilia patients need transfusion of cryoprecipitate, Fresh Frozen Plasma (FFP) or factor concentrate as replacement therapy. Oral surgery, dental extraction, circumcision, and orthopedic operations are the most important indications for fibrin glue in hemophilia care. A s haemostatic local, FG minimizes bleeding, reducing the need of transfusion or factor concentrate, reducing the complication of transfusion, hospitalization and cost."

"Pabrik PT XYZ Styrene Monomer memiliki potensi improvisasi proses kontrol yang belum dioptimalkan. Sebelum implementasi Advance Process Control dilakukan, pengendalian proses dilakukan dengan cara konvensional, sehingga operasional pabrik menjadi tidak efisien. Dengan menerapkan Advance Process Control (APC), didapatkan manfaat dari implementasi ini yaitu secara garis besar dapat membuat pabrik lebih stabil dalam operasionalnya, dapat mengurangi konsumsi energi dan mendekatkan spesifikasi produk Styrene Monomer sesuai dengan acuan spesifikasi yang ditentukan. Advance Process Control (APC) berhasil diimplementasikan pada PT XYZ dalam 2 area yaitu EB (Ethylbenzene) dan SM (Styrene Monomer), pada 10 unit / equipment yang berbeda, dengan menghasilkan keuntungan hasil optimisasi aktual sebesar US$ 519.953 per tahun. Implementasi Advance Process Control diperhatikan keamanan dalam pengendalian kontrolnya melalui kajian analisa bahaya pekerjaan pada tiap tahapan implementasinya. Pada implementasi dan operasionalnya Advance Process Control melibatkan tenaga ahli dari berbagai disiplin yang memiliki pengalaman sesuai pada bidang teknis terkait yang diperlukan.

---

PT XYZ Styrene Monomer plant has a potential process control optimization that has not been fully utilized. Before Advance Process Control implemented, process control was conducted conventionally, impact to the inefficient plant operations. By implementing Advance Process Control (APC),  the benefit of Advance Process Control (APC) implementation are in general enable to achieve more stable operational unit, reduce energy consumption and pushing against styrene monomer specification closer to the production styrene monomer specification.  Advance Process Control (APC) are implemented on 2 areas there are EB (Ethylbenzene) and SM (Stryrene Monomer), applied in 10 different unit / equipment, with the result of optimization on actual benefit US$ 519.954 per year. Advanced Process Control prioritizes safety in its control management through job hazard analysis at each implementation stage. During its implementation and operation, Advanced Process Control involves experts from various disciplines with relevant experience in the required technical fields."

"Pabrik PT XYZ Styrene Monomer memiliki potensi improvisasi proses kontrol yang belum dioptimalkan. Sebelum implementasi Advance Process Control dilakukan, pengendalian proses dilakukan dengan cara konvensional, sehingga operasional pabrik menjadi tidak efisien. Dengan menerapkan Advance Process Control (APC), didapatkan manfaat dari implementasi ini yaitu secara garis besar dapat membuat pabrik lebih stabil dalam operasionalnya, dapat mengurangi konsumsi energi dan mendekatkan spesifikasi produk Styrene Monomer sesuai dengan acuan spesifikasi yang ditentukan. Advance Process Control (APC) berhasil diimplementasikan pada PT XYZ dalam 2 area yaitu EB (Ethylbenzene) dan SM (Styrene Monomer), pada 10 unit / equipment yang berbeda, dengan menghasilkan keuntungan hasil optimisasi aktual sebesar US$ 519.953 per tahun. Implementasi Advance Process Control diperhatikan keamanan dalam pengendalian kontrolnya melalui kajian analisa bahaya pekerjaan pada tiap tahapan implementasinya. Pada implementasi dan operasionalnya Advance Process Control melibatkan tenaga ahli dari berbagai disiplin yang memiliki pengalaman sesuai pada bidang teknis terkait yang diperlukan.

---

PT XYZ Styrene Monomer plant has a potential process control optimization that has not been fully utilized. Before Advance Process Control implemented, process control was conducted conventionally, impact to the inefficient plant operations. By implementing Advance Process Control (APC), the benefit of Advance Process Control (APC) implementation are in general enable to achieve more stable operational unit, reduce energy consumption and pushing against styrene monomer specification closer to the production styrene monomer specification. Advance Process Control (APC) are implemented on 2 areas there are EB (Ethylbenzene) and SM (Stryrene Monomer), applied in 10 different unit / equipment, with the result of optimization on actual benefit US$ 519.954 per year. Advanced Process Control prioritizes safety in its control management through job hazard analysis at each implementation stage. During its implementation and operation, Advanced Process Control involves experts from various disciplines with relevant experience in the required technical fields."

"Pendahuluan: Salah satu konsentrat faktor pertumbuhan autologus terbaru yang dapat mempercepat proses penyembuhan luka dan meningkatan bioaviabilitas adalah platelet rich fibrin (PRF). Belum ada penelitian aplikasi PRF di luka pasca panen tandur kulit dapat mempercepat proses epitelisasi. Metode: Studi multipel measure dengan general linear model adalah untuk mengevaluasi luka pasca panen tandur kulit, luka pasca panen tandur kulit dibagi menjadi dua kelompok dengan atau tanpa aplikasi PRF pada area tersebut. Untuk mengevaluasi epitelisasi luka di lokasi donor, kami memberikan perawatan luka yang sama pada kedua sisi dan evaluasi foto analisis pada hari ke 1,3, 7, 14 dan 30 menggunakan perangkat lunak ImageJ. Data yang diperoleh dianalisis dengan SPSS 20.0. Nilai P lebih rendah dari 0,05 dianggap signifikan. Hasil: Penggunaan PRF telah membuktikan kemampuannya untuk mempercepat proses epitelialisasi proses penyembuhan situs donor p 0,000. Reaksi inflamasi kelompok PRF (hiperemik, nyeri, hipertermia, dan edema) di situs donor berkurang. Kesimpulan: Aplikasi PRF akan memperbaiki kondisi luka, khususnya dengan menyediakan faktor pertumbuhan di lingkungan luka yang membantu mempercepat proses epitelisasi dan menghasilkan manajemen luka yang efektif.

---

Introduction: One of the newest concentrate autologous growth factors for wound healing process is platelet rich fibrin (PRF), used to accelerating wound healing process. PRF application on donor site after skin grafting would accelerated epithelialization process.

Methods: This multiple measure with general linear model study is to evaluate after harvesting, donor site defect was divided into two groups with or without PRF application. To evaluate of epithelialization of donor site wound, we give same treatment of wound care of both side and evaluated at day 1,3, 7, 14 and 30 using ImageJ software. Data obtained were analyzed with SPSS 20.0. The P-values lower than 0.05 considered as significant.

Result: The use of PRF has proven its ability to accelerate the epithelialization process of donor site healing process p 0,000. Inflammation reaction of PRF group (hyperemic, pain, hyperthermia, and edema) on donor site wound less.

Conclusion: PRF application would improve the condition of the wound, in particular by providing growth factor in the wound environment that help accelerate the epithelialization process and resulting in cost effective wound management."

"Pada sepsis terjadi inflamasi sistemik yang menyebabkan ketidakseimbangan mekanisme hemostasis, yaitu, peningkatan aktivasi koagulasi, penurunan antikoagulan alamiah, dan penurunan aktivitas fibrinolisis. Ketidakseimbangan ini bermanifestasi pada pembentukan trombus mikrovaskular yang menyebabkan perfusi jaringan menurun, terjadi disfungsi organ dan kematian. Tujuan penelitian ini mengetahui peranan kadar D-dimer, kadar FDP dan rasio FDP/D-dimer dalam memprediksi mortalitas 14 hari pada pasien sepsis. Penilaian skor Acute physiology and Chronic Health Evaluation II (APACHE II) digunakan untuk memprediksi morbiditas dan mortalitas. Desain penelitian potong lintang, penyajian data secara deskriptif. Subjek penelitian berjumlah 55 orang yang terdiri dari 32 laki-laki dan 23 perempuan dengan rerata usia 51,62 tahun. Pada subjek penelitian, dinilai korelasi kadar FDP, kadar D-dimer, dan rasio FDP/D-dimer dengan skor APACHE II. Pada hasil penelitian, didapatkan 20 pasien hidup dan 35 pasien meninggal. Median kadar FDP (12,9μg/mL) dan kadar D-dimer (7μg/mL) subjek meninggal lebih tinggi dibandingkan median kadar FDP (10,9μg/mL) dan kadar D-dimer (5,2 μg/mL) subjek hidup. Median rasio FDP/D-dimer subjek meninggal (1,9) lebih rendah dibandingkan subjek hidup (2,1). Koefisien korelasi Spearman antara kadar FDP, kadar D-dimer, dan rasio FDP/D-dimer dengan skor APACHE II berturut-turut 0,176, 0,187, dan -0,182. Ketiga korelasi itu secara statistik tidak bermakna (p ≥ 0,05). Pada penelitian ini disimpulkan bahwa kadar FDP, kadar D-dimer, dan rasio FDP/D-dimer tidak dapat digunakan sebagai prognosis keluaran sepsis pada mortalitas 14 hari.

---

Systemic inflamation in sepsis could leads to an imbalance homeostatic mechanisms including elevated coagulation activity, decreasing level of natural anticoagulant, and decreased fibrinolysis activity. This could leads to formation of microvascular thrombus which eventually will cause tissue hypoperfusion, organ dysfunction and death. The aim of this research is to understand the role of d-dimer and fibrin degradation products (FDP) and FDP/d-dimer ratio in predicting 14-days mortality rate on sepsis patient. The morbidity and mortality rate on this research were based on APACHE II scoring system. This is a cross sectional research and all data are presented in a descriptive report. Participant of this research was 55 people (32 male and 23 female), average age was 51,62 years old. This research evaluate the correlation between FDP level, d-dimer level and FDP/d-dimer ratio with APACHE II scoring system. From all the participant we had 20 subject alive and 35 died during this research. The median level of FDP (12,9μg/mL) and d-dimer (7μg/mL) in those who die were higher than those who live (10,9μg/mL and 5,2 μg/mL). The median FDP/d-dimer ratio in those who die (1,9) was lower comparing to those who live (2,1). Spearman coefficient of correlation between FDP level, d-dimer level and FDP/d-dimer ratio with APACHE II scoring system were 0.176; 0.187; and -0.182 repectively. This was not significant statistically (p ≥ 0,05). This research has come to a conclusion that FDP and d-dimer level, and FDP/d-dimer ratio cant be used as a prognostic outcome in sepsis on 14 days mortality."

"Pada sepsis terjadi inflamasi sistemik yang menyebabkan ketidakseimbangan mekanisme hemostasis, yaitu, peningkatan aktivasi koagulasi, penurunan antikoagulan alamiah, dan penurunan aktivitas fibrinolisis. Ketidakseimbangan ini bermanifestasi pada pembentukan trombus mikrovaskular yang menyebabkan perfusi jaringan menurun, terjadi disfungsi organ dan kematian. Tujuan penelitian ini mengetahui peranan kadar D-dimer, kadar FDP dan rasio FDP/D-dimer dalam memprediksi mortalitas 14 hari pada pasien sepsis. Penilaian skor Acute physiology and Chronic Health Evaluation II (APACHE II) digunakan untuk memprediksi morbiditas dan mortalitas. Desain penelitian potong lintang, penyajian data secara deskriptif. Subjek penelitian berjumlah 55 orang yang terdiri dari 32 laki-laki dan 23 perempuan dengan rerata usia 51,62 tahun. Pada subjek penelitian, dinilai korelasi kadar FDP, kadar D-dimer, dan rasio FDP/D-dimer dengan skor APACHE II. Pada hasil penelitian, didapatkan 20 pasien hidup dan 35 pasien meninggal. Median kadar FDP (12,9μg/mL) dan kadar D-dimer (7μg/mL) subjek meninggal lebih tinggi dibandingkan median kadar FDP (10,9μg/mL) dan kadar D-dimer (5,2 μg/mL) subjek hidup. Median rasio FDP/D-dimer subjek meninggal (1,9) lebih rendah dibandingkan subjek hidup (2,1). Koefisien korelasi Spearman antara kadar FDP, kadar D-dimer, dan rasio FDP/D-dimer dengan skor APACHE II berturut-turut 0,176, 0,187, dan -0,182. Ketiga korelasi itu secara statistik tidak bermakna (p ≥ 0,05). Pada penelitian ini disimpulkan bahwa kadar FDP, kadar D-dimer, dan rasio FDP/D-dimer tidak dapat digunakan sebagai prognosis keluaran sepsis pada mortalitas 14 hari.

---

Systemic inflamation in sepsis could leads to an imbalance homeostatic mechanisms including elevated coagulation activity, decreasing level of natural anticoagulant, and decreased fibrinolysis activity. This could leads to formation of microvascular thrombus which eventually will cause tissue hypoperfusion, organ dysfunction and death. The aim of this research is to understand the role of d-dimer and fibrin degradation products (FDP) and FDP/d-dimer ratio in predicting 14-days mortality rate on sepsis patient. The morbidity and mortality rate on this research were based on APACHE II scoring system. This is a cross sectional research and all data are presented in a descriptive report. Participant of this research was 55 people (32 male and 23 female), average age was 51,62 years old. This research evaluate the correlation between FDP level, d-dimer level and FDP/d-dimer ratio with APACHE II scoring system. From all the participant we had 20 subject alive and 35 died during this research. The median level of FDP (12,9μg/mL) and d-dimer (7μg/mL) in those who die were higher than those who live (10,9μg/mL and 5,2 μg/mL). The median FDP/d-dimer ratio in those who die (1,9) was lower comparing to those who live (2,1). Spearman coefficient of correlation between FDP level, d-dimer level and FDP/d-dimer ratio with APACHE II scoring system were 0.176; 0.187; and – 0.182 repectively. This was not significant statistically (p ≥ 0,05). This research has come to a conclusion that FDP and d-dimer level, and FDP/d-dimer ratio cant be used as a prognostic outcome in sepsis on 14 days mortality."